Roberto Botelho

Showing 1-3 of 3 articles

Author Stefan Verheye

Coronary interventions

Five Year Safety and Performance Data of a Novel Third Generation Novolimus-eluting Bio-resorbable Scaffold in a Single De-novo Lesion

Verheye S, Costa RA, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamie D, Abizaid AS, Boersma E, Abizaid A

December 11, 2018 | 10.4244/EIJ-D-18-00292

Author Alexandre A. Abizaid

Coronary interventions

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S

December 7, 2018 | 10.4244/EIJ-D-18-00762

Author J. Ribamar Costa Jr

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Perin M, Seth A, Botelho R, Serruys P

June 19, 2015 | 10.4244/EIJY15M05_06

1

Latest news

From robotics, the impact of diabetes in DAPT to PVE after TAVI and SURF - the future, now in EuroIntervention

(Cover Image: Robotic PCI)

Read this week's JAA's on the REDUCE trial, SORT OUT III Study, IMP-IT registry and much more

August 20, 2019

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

Special subscription offer!

Register before the end of August and save up to 40% on the regular rates

Guidance papers

Guidelines, consensus & position papers

Last Update: Augustus, PARTNER III, NOTION...

(The Trials book is supported by Biotronik)

Read this week's JAA's on PCI vs CABG and Snuffbox

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke